1. Go RS, Wester SM. Immunophenotypic and molecular features, clinical outcomes, treatments, and prognostic factors associated with subcutaneous panniculitis-like T-cell lymphoma: a systematic analysis of 156 patients reported in the literature. Cancer. 2004; 101:1404–13.
2. Parveen Z, Thompson K. Subcutaneous panniculitis-like T-cell lymphoma: redefinition of diagnostic criteria in the recent World Health Organization-European Organization for Research and Treatment of Cancer classification for cutaneous lymphomas. Arch Pathol Lab Med. 2009; 133:303–8.
Article
3. Willemze R, Jansen PM, Cerroni L, Berti E, Santucci M, Assaf C, et al. Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases. Blood. 2008; 111:838–45.
Article
4. Foss FM, Edelson RL, Wilson LD. Lymphomas: cutaneous T-cell lymphomas. In : DeVita VT, Hellman S, Rosenberg SA, editors. DeVita, Hellman, and Rosenberg`s cancer: principles and practice of oncology. Philadelphia: Lippincott Williams & Wilkins;2005. p. 2143–58.
5. Rojnuckarin P, Nakorn TN, Assanasen T, Wannakrairot P, Intragumtornchai T. Cyclosporin in subcutaneous panniculitislike T-cell lymphoma. Leuk Lymphoma. 2007; 48:560–3.
Article
6. Go SI, Lee WS, Kang MH, Kim IS, Kim DC, Lee JH. Cyclosporine A treatment for relapsed subcutaneous panniculitis- like T-cell lymphoma: a case with long-term follow-up. Korean J Hematol. 2012; 47:146–9.
7. Mizutani S, Kuroda J, Shimura Y, Kobayashi T, Tsutsumi Y, Yamashita M, et al. Cyclosporine A for chemotherapy-resistant subcutaneous panniculitis-like T cell lymphoma with hemophagocytic syndrome. Acta Haematol. 2011; 126:8–12.
Article
8. Jung HR, Yun SY, Choi JH, Bae SH, Ryoo HM, Kum YS. Cyclosporine in relapsed subcutaneous panniculitis-like T-cell lymphoma after autologous hematopoietic stem cell transplantation. Cancer Res Treat. 2011; 43:255–9.
Article
9. Shani-Adir A, Lucky AW, Prendiville J, Murphy S, Passo M, Huang FS, et al. Subcutaneous panniculitic T-cell lymphoma in children: response to combination therapy with cyclosporine and chemotherapy. J Am Acad Dermatol. 2004; 50(2 Suppl):S18–22.
Article
10. Al Zolibani AA, Al Robaee AA, Qureshi MG, Al Nosian H. Subcutaneous panniculitis-like T-cell lymphoma with hemophagocytic syndrome successfully treated with cyclosporin A. Skinmed. 2006; 5:195–7.
Article
11. Chen R, Liu L, Liang YM. Treatment relapsed subcutaneous panniculitis-like T-cell lymphoma together HPS by cyclosporin A. Hematol Rep. 2010; 2:e9.
Article
12. Tsukamoto Y, Katsunobu Y, Omura Y, Maeda I, Hirai M, Teshima H, et al. Subcutaneous panniculitis-like T-cell lymphoma: successful initial treatment with prednisolone and cyclosporin A. Intern Med. 2006; 45:21–4.
Article
13. Marzano AV, Berti E, Paulli M, Caputo R. Cytophagic histiocytic panniculitis and subcutaneous panniculitis-like T-cell lymphoma: report of 7 cases. Arch Dermatol. 2000; 136:889–96.
Article
14. von den Driesch P, Staib G, Simon M Jr, Sterry W. Subcutaneous T-cell lymphoma. J Am Acad Dermatol. 1997; 36(2 Pt 2):285–9.
Article